Berlin - Delayed Quote EUR

Iovance Biotherapeutics Inc (2LB.BE)

Compare
5.73
+0.15
+(2.69%)
As of 8:02:36 AM GMT+1. Market Open.
Loading Chart for 2LB.BE
DELL
  • Previous Close 5.58
  • Open 5.73
  • Bid 5.77 x --
  • Ask 5.85 x --
  • Day's Range 5.73 - 5.73
  • 52 Week Range 5.58 - 16.50
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2LB.BE

View More

Performance Overview: 2LB.BE

Trailing total returns as of 1/20/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

2LB.BE
18.36%
S&P 500
1.52%

1-Year Return

2LB.BE
20.82%
S&P 500
23.90%

3-Year Return

2LB.BE
54.59%
S&P 500
32.30%

5-Year Return

2LB.BE
72.99%
S&P 500
80.10%

Compare To: 2LB.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2LB.BE

View More

Valuation Measures

As of 1/17/2025
  • Market Cap

    1.75B

  • Enterprise Value

    1.44B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    17.55

  • Price/Book (mrq)

    2.26

  • Enterprise Value/Revenue

    16.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2LB.BE

View More